Correction: Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

• Kenji Fujiwara,
• Hao Jing,
• Brian Herbst,
• MacKenzie Zarecki,
• Annie Wu,
• Elaine Bigelow,
• Keyu Li,
• Neolle Jurcak,
• Alex B Blair,
• Michael Wichroski,
• Jordan Blum,
• Nathan Cheadle,
• Jennifer Koenitzer

Affiliations

Kenji Fujiwara

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States

Hao Jing

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States

Brian Herbst

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States

MacKenzie Zarecki

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States

Annie Wu

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States

Elaine Bigelow

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States

Keyu Li

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States

Neolle Jurcak

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States

Alex B Blair

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States

Michael Wichroski

Bristol Myers Squibb Co, Princeton, New Jersey, USA

Jordan Blum

Bristol Myers Squibb Co, Princeton, New Jersey, USA

Nathan Cheadle

Bristol Myers Squibb Co, Princeton, New Jersey, USA

Jennifer Koenitzer

Bristol Myers Squibb Co, Princeton, New Jersey, USA